Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02954562 · ClinicalTrials.gov registry record
Correlates of Anxiety Associated With a Life-threatening Illness
A clinical trial, sponsored by Resilient Pharmaceuticals.
- Completed
- Registry status
- 12
- Enrollment target
NCT02954562: Completed study, sponsored by Resilient Pharmaceuticals.
NCT02954562 is a clinical trial that has completed, run by Resilient Pharmaceuticals. The registered enrollment target is 12 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02954562 has completed, sponsored by Resilient Pharmaceuticals.
- COMPLETED
- Registry status
- 12 participants
- Enrollment target
Study Summary
The goal of this observational trial is to gather brain scan data on people undergoing MDMA-assisted therapy. The main question it aims to answer is: -How does brain activity change while completing an emotional regulation task in participants receiving MDMA-assisted therapy? Researchers will compare participants receiving MDMA-assisted therapy to participants receiving placebo plus therapy. Participants will undergo baseline brain scans with functional magnetic imaging (fMRI) while they perform an emotional regulation task and other attentional tasks. Participants will then undergo two medication sessions of MDMA or placebo-assisted therapy. Then, undergo another brain scan. Participants will then undergo a third medication session and repeat the brain scans.
Interventions
- OTHER fMRI
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2015-11-07 |
| Est. Completion | 2017-09-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02954562
The ClinicalTrials.gov registry entry for NCT02954562 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Resilient Pharmaceuticals, which has 17 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which fMRI is the first listed.
NCT02954562 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02954562 about?
NCT02954562 is a clinical study titled "Correlates of Anxiety Associated With a Life-threatening Illness". The goal of this observational trial is to gather brain scan data on people undergoing MDMA-assisted therapy. The main question it aims to answer is: -How does brain activity change while completing an emotional regulation task in participants receiving MDMA-assisted therapy? Researchers will comp...
What is the current status of trial NCT02954562?
This trial is currently completed. The enrollment target is 12 participants. The study started on 2015-11-07. Estimated completion is 2017-09-30.
What interventions are being tested in trial NCT02954562?
The interventions under investigation include: fMRI (OTHER).
Who is sponsoring clinical trial NCT02954562?
This trial is sponsored by Resilient Pharmaceuticals, which has 17 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.